Company attributes
Location
Legal Name
Delix Therapeutics, Inc.
Email Address
info@delixtherapeutics.com
Investors
Founded Date
2019
Total Funding Amount (USD)
100,000,000
Latest Funding Round Date
January 11, 2022
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
30,000,000
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale.
Timeline
No Timeline data yet.
